Your browser doesn't support javascript.
loading
Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19.
Berry, Donald A; Ip, Andrew; Lewis, Brett E; Berry, Scott M; Berry, Nicholas S; MrKulic, Mary; Gadalla, Virginia; Sat, Burcu; Wright, Kristen; Serna, Michelle; Unawane, Rashmi; Trpeski, Katerina; Koropsak, Michael; Kaur, Puneet; Sica, Zachary; McConnell, Andrew; Bednarz, Urszula; Marafelias, Michael; Goy, Andre H; Pecora, Andrew L; Sawczuk, Ihor S; Goldberg, Stuart L.
Afiliação
  • Berry DA; Berry Consultants LLC, Austin, Texas, United States of America.
  • Ip A; M.D. Anderson Cancer Center of the University of Texas, Houston, Texas, United States of America.
  • Lewis BE; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Berry SM; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Berry NS; Hackensack Meridian Health School of Medicine, Nutley, New Jersey, United States of America.
  • MrKulic M; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Gadalla V; Hackensack Meridian Health School of Medicine, Nutley, New Jersey, United States of America.
  • Sat B; Berry Consultants LLC, Austin, Texas, United States of America.
  • Wright K; Berry Consultants LLC, Austin, Texas, United States of America.
  • Serna M; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Unawane R; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Trpeski K; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Koropsak M; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Kaur P; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Sica Z; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • McConnell A; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Bednarz U; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Marafelias M; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Goy AH; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Pecora AL; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Sawczuk IS; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Goldberg SL; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
PLoS One ; 16(7): e0255228, 2021.
Article em En | MEDLINE | ID: mdl-34329317
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mortalidade Hospitalar / SARS-CoV-2 / COVID-19 / Hospitalização / Modelos Biológicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mortalidade Hospitalar / SARS-CoV-2 / COVID-19 / Hospitalização / Modelos Biológicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos